Evolving Evidence-Based Treatment Guidelines for Iron Deficiency Anemia in Inflammatory Bowel Disease: Considerations in Managed Care

Evolving Evidence-Based Treatment Guidelines for Iron Deficiency Anemia in Inflammatory Bowel Disease: Considerations in Managed Care

An American Journal of Managed Care® Supplement

Faculty
Nicole M. Bohm, PharmD, BCPS
Associate Professor and Clinical Pharmacy Specialist, Internal Medicine
Department of Clinical Pharmacy and Outcomes Sciences
College of Pharmacy
Medical University of South Carolina
Charleston, South Carolina

Jeenal Patel, PharmD, BCGP
Associate Director, Formulary Design and Strategy
Oscar Health
Lakeland, Florida

Medical Writing & Editorial Support

Brittany Hoffmann-Eubanks, PharmD, MBA
Owner
Banner Medical, LLC
Frankfort, Illinois

Jenna Wood, PharmD
Clinical Pharmacist
Columbus, Ohio
 
Program Description
Iron deficiency anemia (IDA) is closely linked to inflammatory bowel disease (IBD). Treatment often consists of iron replacement therapy, and novel intravenous (IV) iron formulations have impacted the management of patients with both IBD and IDA. Managed care professionals must understand the role of IV iron in treating patients with IBD and IDA, as well as safety and efficacy considerations. This activity will review the role of IV iron replacement in IBD and IDA and focus on the economic burden of these disease states and the impact of IV iron on healthcare resource use.

Target Audience: Managed care pharmacists
Type of Activity: Application
Release date: July 15, 2021
Expiration date: July 15, 2022
Time to complete activity: 2 hours
Fee: Free

Educational Objectives
At the completion of this activity, participants will be able to:

• Examine the biologic pathways relevant to iron hemostasis in inflammatory bowel disease (IBD) as well as appropriate monitoring of iron status.
• Compare iron replacement therapies, including risks and benefits, for the treatment of patients with IBD and iron deficiency.
• Explore the health-related quality of life and economic burden of iron deficiency anemia in relation to the evolving evidence-based treatment protocols for patients with IBD and iron deficiency to improve outcomes and efficiently allocate healthcare resources.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEU) under the ACPE universal activity number 0290-0000-21-265-H01-P. The activity is available for CE credit through July 15, 2022.


Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, read the online article in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
 

---

Disclosures

Faculty

Nicole Bohm, PharmD, BCPS, has the following relevant financial relationships with commercial interests to disclose:
Consultant: Wolters Kluwer, TRC Pharmacist’s Letter

Jeenal Patel, PharmD, BCGP, has no relevant financial relationships with commercial interests to disclose.

Medical Writing and Editorial Support

Brittany Hoffmann-Eubanks, PharmD, MBA, and Jenna Wood, PharmD, have no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Kimberly Simpson, PharmD; Meg Taylor, PharmD, CPP; Liz Rauh; Susan Pordon; Brianna Winters and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Disclosure Policy
According to the disclosure policy of The American Journal of Managed Care® and Pharmacy Times Continuing Education™, all persons who are in a position to control content are required to disclose any relevant financial relationships with commercial interests. If a conflict is identified, it is the responsibility of Pharmacy Times Continuing Education™ to initiate a mechanism to resolve the conflict(s). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

Disclosure of Unapproved/Off-Label Use
The contents of this activity may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Participants should note that the use of these products outside current approved labeling is considered experimental and they are advised to consult prescribing information for these products.

The information provided in this CE activity is for continuing medical and pharmacy education purposes only and is not meant to substitute for the independent medical or pharmacy judgment of a physician or pharmacist relative to diagnostic, treatment, or management options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of The American Journal of Managed Care®, Pharmacy Times Continuing Education™, or the company that provided commercial support for this CE activity.

Signed disclosures are on file at the office of The American Journal of Managed Care®, Cranbury, New Jersey.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms